Our previous study has reported that NDR1 inhibited the metastasis of prostate cancer cells by suppressing epithelial-mesenchymal transition (EMT), and decreased NDR1 expression might lead to a poorer prognosis (Yue et al., 2018). This evidence concerns the gene STK38 and prostate carcinoma.